title: Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine.
authors.forename: E
authors.initials: E
authors.lastname: Pascale
authors.forename: E
authors.initials: E
authors.lastname: Battiloro
authors.forename: G
authors.initials: G
authors.lastname: Cimino Reale
authors.forename: R
authors.initials: R
authors.lastname: Pietrobono
authors.forename: M G
authors.initials: MG
authors.lastname: Pomponi
authors.forename: P
authors.initials: P
authors.lastname: Chiurazzi
authors.forename: R
authors.initials: R
authors.lastname: Nicolai
authors.forename: M
authors.initials: M
authors.lastname: Calvani
authors.forename: G
authors.initials: G
authors.lastname: Neri
authors.forename: E
authors.initials: E
authors.lastname: D'Ambrosio
mesh_terms: D000108:Acetylcarnitine / Q000627:therapeutic use*; D002331:Carnitine / Q000627:therapeutic use*; D002478:Cells, Cultured; D019175:DNA Methylation / Q000187:drug effects*; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000235:genetics* / Q000378:metabolism*; D018697:Nootropic Agents / Q000627:therapeutic use; D011401:Promoter Regions, Genetic / Q000187:drug effects*; D016601:RNA-Binding Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D000108:Acetylcarnitine; D002331:Carnitine; D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D018697:Nootropic Agents; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human